May 8, 2002
AMERIPATH, INC. TO PRESENT AT DEUTSCHE BANK SECURITIES HEALTHCARE CONFERENCE

Riviera Beach, FL, May 8, 2002 – AmeriPath, Inc. (Nasdaq:PATH), one of the nation’s leading providers of anatomic pathology services, today announced it will participate in the Deutsche Bank Securities Healthcare Conference to be held at the The Baltimore Marriott Waterfront Hotel in Baltimore, Maryland. The Company’s President, Brian C. Carr, will make the AmeriPath presentation on Thursday, May 9, 2002, at 12:30 p.m., Eastern Time.

The public is invited to listen to a webcast of the live presentation via the Internet through the Deutsche Bank website http://www.db.com/conferences. The webcast and replay will also be available on the AmeriPath website, http://www.ameripath.com/.

AmeriPath is a leading national provider of cancer diagnostics, genomics, and related information services. The Company’s extensive diagnostics infrastructure includes the Center for Advanced Diagnostics (CAD), a division of AmeriPath. CAD provides specialized diagnostic testing and information services including Fluorescence In-Situ Hybridization (FISH), Flow Cytometry, DNA Analysis, Polymerase Chain Reaction (PCR), Molecular Genetics, Cytogenetics and HPV Typing. Additionally, AmeriPath provides clinical trial and research development support to firms involved in developing new cancer and genomic diagnostics and therapeutics.